Literature DB >> 15611037

Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.

Harald Fischer1, Avi Orr-Urtreger, Lorna W Role, Sigismund Huck.   

Abstract

We have compared the functional properties of nicotinic acetylcholine receptors (nAChRs) within both somatic and presynaptic domains of superior cervical ganglion (SCG) neurones from wild-type (WT) mice with those expressed by SCG neurones from mice with a targeted deletion of the gene for the alpha5-subunit. The functional profile of somatic nAChRs was assayed by direct macroscopic current recording and from measurements of nicotinic agonist-induced calcium transients with fura-2 imaging. The profile of nAChRs at presynaptic sites was assayed by measurement of nicotinic agonist-induced transmitter release (as preloaded [3H]noradrenaline) under conditions of action potential blockade. We have examined the responses to the nicotinic agonists acetylcholine, nicotine, cytisine, dimethylphenylpiperazinium iodide (DMPP) and epibatidine. Macroscopic current and calcium imaging assays revealed several differences in the functional profile of somatic nAChRs in WT SCG neurones compared with those from mice with the alpha5 subunit deleted. Somatic nAChRs in control animals were more potently activated by cytisine as compared to DMPP. In contrast, DMPP was consistently more potent than cytisine in mice lacking the alpha5 nAChR subunit. Differences in the somatic nAChR rank order of potency were most prominent after a least 1 day in vitro. The magnitude of somatic nAChR responses to nicotinic agonists was not substantially different in control mice compared with those of alpha5 subunit-deleted animals. Comparison of presynaptic nAChR-mediated responses in WT versus alpha5 subunit-deleted animals revealed a very different set of changes in the functional profile of prejunctional nAChRs compared with somatic nAChRs. In contrast to somatic nAChRs, the responses of prejunctional receptors were markedly enhanced in alpha5 knockout animals compared with control. Furthermore, all prejunctional receptor responses were most potently activated by DMPP in both control and in alpha5 subunit-deleted mice. Hence, the presence or absence of the alpha5 subunit did not affect the rank order of potency of agonists at preterminal sites but greatly affected the magnitude of presynaptic nAChR-mediated responses. The enhanced efficacy of nicotine at presynaptic receptors was corroborated in an acute atrium preparation from postnatal alpha5 subunit-deleted mice. These results confirm and significantly extend our previous observation that in the sympathetic nervous system, somatic and prejunctional receptors are different and rely on the presence of the alpha5 subunit in a distinct manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611037      PMCID: PMC1665561          DOI: 10.1113/jphysiol.2004.075788

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  Target-specific control of nicotinic receptor expression at developing interneuronal synapses in chick.

Authors:  P Devay; D S McGehee; C R Yu; L W Role
Journal:  Nat Neurosci       Date:  1999-06       Impact factor: 24.884

2.  Low access resistance perforated patch recordings using amphotericin B.

Authors:  J Rae; K Cooper; P Gates; M Watsky
Journal:  J Neurosci Methods       Date:  1991-03       Impact factor: 2.390

3.  Acetylcholine-induced release of norepinephrine in the presence of tetrodotoxin.

Authors:  K R Krauss; D O Carpenter; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1970-06       Impact factor: 4.030

Review 4.  Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

Authors:  D S McGehee; L W Role
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

5.  Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions.

Authors:  W G Conroy; D K Berg
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

6.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

8.  Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor.

Authors:  Ningshan Wang; Avi Orr-Urtreger; Joab Chapman; Ruth Rabinowitz; Amos D Korczyn
Journal:  J Neurol Sci       Date:  2004-07-15       Impact factor: 3.181

9.  Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes.

Authors:  P J Covernton; H Kojima; L G Sivilotti; A J Gibb; D Colquhoun
Journal:  J Physiol       Date:  1994-11-15       Impact factor: 5.182

10.  Mice lacking neuronal nicotinic acetylcholine receptor beta4-subunit and mice lacking both alpha5- and beta4-subunits are highly resistant to nicotine-induced seizures.

Authors:  Merav Kedmi; Arthur L Beaudet; Avi Orr-Urtreger
Journal:  Physiol Genomics       Date:  2004-04-13       Impact factor: 3.107

View more
  18 in total

Review 1.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

2.  α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion.

Authors:  Petra Scholze; Anna Ciuraszkiewicz; Florian Groessl; Avi Orr-Urtreger; J Michael McIntosh; Sigismund Huck
Journal:  Dev Neurobiol       Date:  2011-05       Impact factor: 3.964

Review 3.  The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.

Authors:  Ma Reina D Improgo; Michael D Scofield; Andrew R Tapper; Paul D Gardner
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

4.  Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.

Authors:  Loredana Riganti; Cosetta Matteoni; Silvia Di Angelantonio; Andrea Nistri; Annalisa Gaimarri; Fabio Sparatore; Caterina Canu-Boido; Francesco Clementi; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

5.  Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes.

Authors:  Reinhard David; Anna Ciuraszkiewicz; Xenia Simeone; Avi Orr-Urtreger; Roger L Papke; J M McIntosh; Sigismund Huck; Petra Scholze
Journal:  Eur J Neurosci       Date:  2010-03-03       Impact factor: 3.386

Review 6.  Nicotinic regulation of energy homeostasis.

Authors:  Michele Zoli; Marina R Picciotto
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

7.  Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation.

Authors:  P Scholze; A Orr-Urtreger; J-P Changeux; J M McIntosh; S Huck
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

Review 8.  Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds.

Authors:  Jennifer A Wilking; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

9.  Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells.

Authors:  Paraskevi Krashia; Mirko Moroni; Steven Broadbent; Giovanna Hofmann; Sebastian Kracun; Marco Beato; Paul J Groot-Kormelink; Lucia G Sivilotti
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 10.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.